How to Buy Abeona Therapeutics Stock
Abeona Therapeutics Inc
Abeona Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases.
Abeona Therapeutics stock last closed at $5.11, down 1.54% from the previous day, and has decreased 3.58% in one year. It has overperformed other stocks in the Biotechnology industry by 0.29 percentage points. Abeona Therapeutics stock is currently +29.93% from its 52-week low of $3.93, and -32.23% from its 52-week high of $7.54.
There are currently 54.19M shares of ABEO outstanding. The market cap of ABEO is $276.92M. In the last 24 hours, 1.05M ABEO shares were traded.
How to Buy Abeona Therapeutics Stock
Not sure how to invest in Abeona Therapeutics stock? Here's how.
- Decide where to buy Abeona Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Abeona Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your method of payment and add your details.
- Analyze Abeona Therapeutics stock: The Abeona Therapeutics ticker symbol is ABEO. Is Abeona Therapeutics stock a good investment? Should you buy shares of ABEO? How do ABEO's underlying business fundamentals look? Do top analysts think Abeona Therapeutics is a good buy? Why has ABEO's stock price moved recently? (Hint: Our stock analysis website can help you understand if ABEO is a good stock to buy).
- Make your ABEO trade: Decide if you will purchase ABEO shares at the current market price or use a limit order to purchase ABEO shares at a given price.
- Keep an eye on your ABEO investment: Create a watchlist to the latest updates on your new investment in Abeona Therapeutics shares.
Step 1: Decide where to buy Abeona Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy ABEO stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in ABEO stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create your new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on the best investment app, your next step is to transfer the money for your investment:
Watch the walkthrough below for more details transferring funds into your brokerage account.
Step 4: Analyze Abeona Therapeutics stock
Once you have selected the best place to buy Abeona Therapeutics stock, it's crucial to research their stock prior to investing, so you can understand the risk as well as the upside.
Abeona Therapeutics quick stats
Abeona Therapeutics Due Diligence Checks
WallStreetZen was designed to help average investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on ABEO's stock page.
What is the fair value of ABEO stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge ABEO's intrinsic value.
Using relative valuations metrics:
- ABEO could be undervalued based on its P/E ratio of 3.21x, relative to Biotechnology industry P/E ratio of 162.68x
- ABEO may be undervalued based on its P/B ratio of 1.62x, relative to Biotechnology industry P/B ratio of 5.64x
- ABEO could be undervalued based on its PEG ratio of 0.19x
You can access more valuation research on ABEO's stock here.
ABEO Financials at a glance
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the ABEO balance sheet.
- ABEO has a low debt to equity ratio of 0.35.
- Total ABEO debt is lower than 5 years ago, relative to shareholder equity.
- ABEO has $207.46M in cash and short term investments. This is enough to cover its annual cash burn of $82.36M.
- ABEO has cash burn of 82360000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the ABEO balance sheet.
Do analysts think it's a good time to buy ABEO stock
Out of 2 Wall Street analysts who research ABEO, the consensus analyst rating on ABEO is a Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Abeona Therapeutics stock forecast page.
ABEO Technicals
How is ABEO performing as a company?
Last year, ABEO revenue was $400.00k. In the past five year, ABEO's revenue has grown by -43.59% per year. This was slower than the Biotechnology industry average of 43.09%.
You can research ABEO's earnings and revenue performance here.
Latest Insiders Trades at ABEO
In the last year, insiders at ABEO have sold more shares than they have bought.
Brendan M. Omalley, SVP Chief Legal Officer of ABEO, was the latest ABEO insider to sell. They sold $72,384.32 worth of ABEO shares on Jan 22, 2026.
Learn more about who owns ABEO shares here.
Does ABEO stock generate passive income?
No, Abeona Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about ABEO?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your ABEO trade
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open Trade button and eToro will execute your order.
If you need more help with buying stocks on eToro, click the how to video below:
Step 6: Keep an eye on your ABEO investment
Now that you own some ABEO stock, you'll want to keep up with your investment.
Put ABEO on a watchlist to get notified of important updates regarding your ABEO stock.
ABEO Feed
How to Buy Stock in Abeona Therapeutics
To reiterate, here are the 6 steps you need to take to buy Abeona Therapeutics stock right now:
- Decide where to buy Abeona Therapeutics stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Analyze Abeona Therapeutics stock
- Make your ABEO trade
- Keep an eye on your ABEO investment
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep tabs on your investment in Abeona Therapeutics, hit the button below to create your watchlist.
More Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.